CRP and Sepsis: In this cohort study of 483 patients who survived hospitalization with sepsis at 12 US hospitals, 25.8% had elevated high-sensitivity C-reactive protein levels (a marker of inflammation) at 3 months, 30.2% at 6 months, and 25.6% at 12 months and 46.4% had elevated soluble programmed death ligand 1 levels (a marker of immunosuppression) at 3 months, 44.9% at 6 months, and 49.4% at 12 months.